Sorry, you need to enable JavaScript to visit this website.
Latest News
June 19, 2020
Women empowerment in times of COVID-19
Bayer supports “The Challenge Initiative” of Johns Hopkins Bloomberg School of Public Health with 10 million USD
June 17, 2020
Not intended for U.S. and UK Media
Bayer to highlight latest research on its advancing Oncology portfolio at the AACR20 Virtual Annual Meeting II
June 15, 2020
Not intended for U.S. and UK Media
Bayer extends clinical development program for finerenone with Phase III study in patients with heart failure and preserved ejection fraction
June 05, 2020
Not intended for U.S. and UK Media
Bayer submits vericiguat for marketing authorization in the EU and Japan for the treatment of chronic heart failure
May 29, 2020
Not intended for U.S. and UK Media - American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program):
Efficacy of Vitrakvi™ (larotrectinib) further established with continued high response rates and durable response in updated analyses in adult patients and quality of life data in adult and pediatric patients with TRK fusion cancer
Global Health Policy Blog
Current Topics
All